Skip to main content

MoneyWorks4Me

Divis Laboratories informs about disclosure

15 Mar 2019 Evaluate

Divis Laboratories has informed that exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Reliance Nippon Life Asset Management.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1769.00
Dr. Reddys Labs. 1357.85
Cipla 1377.50
Lupin 2027.10
Zydus Lifesciences 1238.10
View more..